Unique Wealth Strategies’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Hold
7,992
0.46% 46
2026
Q1
$1.22M Sell
7,992
-2,454
-23% -$376K 0.5% 46
2025
Q4
$1.44M Sell
10,446
-70
-0.7% -$9.17K 0.56% 42
2025
Q3
$1.35M Buy
10,516
+155
+1% +$18.9K 0.52% 44
2025
Q2
$1.25M Buy
10,361
+69
+0.7% +$7.78K 0.52% 40
2025
Q1
$1.15M Sell
10,292
-115
-1% -$12.2K 0.52% 47
2024
Q4
$1.01M Sell
10,407
-351
-3% -$37.4K 0.44% 53
2024
Q3
$1.24M Buy
10,758
+932
+9% +$106K 0.52% 51
2024
Q2
$950K Hold
9,826
0.45% 63
2024
Q1
$950K Buy
9,826
+1,656
+20% +$170K 0.47% 63
2023
Q4
$825K Buy
+8,170
New +$789K 0.55% 59

Other funds holding NVS

Unique Wealth Strategies's NVS Position: Q2 2026 in Review

Unique Wealth Strategies held its Novartis (NVS) position steady in Q2 2026 at 7,992 shares worth $1.25M. The position accounts for 0.46% of the portfolio, ranked #46.

Unique Wealth Strategies first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.44M in Q4 2025. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Unique Wealth Strategies held 7,992 shares of Novartis worth $1.25M as of Q2 2026.
  • Unique Wealth Strategies left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.46% of Unique Wealth Strategies's portfolio in Q2 2026, its #46 holding.
  • Unique Wealth Strategies first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • Unique Wealth Strategies's Novartis position peaked at $1.44M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.